SINGLE VENTRICLE HEART DISEASE
Clinical trials for SINGLE VENTRICLE HEART DISEASE explained in plain language.
Never miss a new study
Get alerted when new SINGLE VENTRICLE HEART DISEASE trials appear
Sign up with your email to follow new studies for SINGLE VENTRICLE HEART DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for failing fontan hearts: common drug gets specialized trial
Disease control Recruiting nowThis study is testing whether a medication called dapagliflozin, taken for six months, can help control heart pressures and improve symptoms in adults with a failing Fontan circulation—a complex heart condition they were born with. Researchers will measure changes in heart pressu…
Matched conditions: SINGLE VENTRICLE HEART DISEASE
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
New hope for fontan teens: major trial tests drug to boost energy and heart health
Disease control Recruiting nowThis study is testing whether a medication called udenafil can help teens who were born with a single ventricle heart and had the Fontan surgery. Researchers want to see if the drug safely improves how well the heart and lungs work during exercise. About 436 participants, aged 12…
Matched conditions: SINGLE VENTRICLE HEART DISEASE
Phase: PHASE3 • Sponsor: Mezzion Pharma Co. Ltd • Aim: Disease control
Last updated Mar 24, 2026 12:03 UTC